| Health / Medical Topics |
BCR/ABL1 Fusion Gene p210
A fusion gene that results from a chromosomal translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene between exons 12 and 16 to the 5' side of exon 2 of the ABL1 gene. This rearrangement is associated with chronic myelogenous leukemia, acute lymphoblastic leukemia and acute myeloid leukemia. (NCI Thesaurus)
YOU MAY ALSO LIKE
A fusion gene that results from a chromosomal translocation t(9;22)(q34;q11) that fuses exon 1 of the BCR gene to the 5' side…
A fusion gene that results from a translocation t(9;22)(q34;q11) that fuses the 5' part of the BCR gene to the 5' side…
Bcr/abl is the gene rearrangement that is associated primarily with the disease chronic myelogenous leukemia and less frequently with acute lymphoblastic…
A molecular genetic abnormality in the kinase domain of the BCR-ABL fusion gene that results in resistance to tyrosine kinase inhibitors. …
A multivalent antineoplastic vaccine comprised of the bcr-abl oncogene breakpoint fusion peptide that elicits a bcr-abl specific T-cell immune response. …
A multipeptide vaccine consisting of five peptides derived from the bcr-abl p210-b3a2 breakpoint fusion protein with potential antineoplastic activity. Vaccination with bcr-abl…
